Evidence map›Paper›PMID 28122876›Full record

ArticleBrain : a journal of neurology2017

Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI.

Natania A Crane, Lisanne M Jenkins, Runa Bhaumik, Catherine Dion, Jennifer R Gowins, Brian J Mickey, Jon-Kar Zubieta, Scott A Langenecker

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 5 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 5 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Cultural adaptation of the facial emotion perception test for use in Zimbabwe: A pilot study.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2025
    Article
  12. Article
  13. Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  14. Neuroimaging for precision medicine in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Natania A CraneThe University of Illinois at Chicago, Department of Psychiatry and the Cognitive Neuroscience Center, Chicago, IL 60612, USA.
Lisanne M JenkinsThe University of Illinois at Chicago, Department of Psychiatry and the Cognitive Neuroscience Center, Chicago, IL 60612, USA.
Runa BhaumikThe University of Illinois at Chicago, Department of Psychiatry and the Cognitive Neuroscience Center, Chicago, IL 60612, USA.
Catherine DionThe University of Illinois at Chicago, Department of Psychiatry and the Cognitive Neuroscience Center, Chicago, IL 60612, USA.
Jennifer R GowinsThe University of Illinois at Chicago, Department of Psychiatry and the Cognitive Neuroscience Center, Chicago, IL 60612, USA.
Brian J MickeyThe University of Michigan Medical School, Department of Psychiatry, Molecular and Behavioral Neuroscience Institute, Ann Arbor, MI 48104, USA.
Jon-Kar ZubietaThe University of Michigan Medical School, Department of Psychiatry, Molecular and Behavioral Neuroscience Institute, Ann Arbor, MI 48104, USA.
Scott A LangeneckerThe University of Illinois at Chicago, Department of Psychiatry and the Cognitive Neuroscience Center, Chicago, IL 60612, USA slangenecker@psych.uic.edu.
University of Illinois Chicago · USUniversity of Michigan–Ann Arbor · US

Funding

ZINC GLUCONATE GLYCINE LOZENGES &VITAMIN C EFFECTS ON COMMON COLDM01RR000042 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELSTROM, REBECCA L · 1985 to 2007
$40.8M
TISSUE SPECIFIC /INDUCIBLE REGULATION RECEPTORS /TRANSGEP01MH042251 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WATSON, STANLEY J · 1987 to 2006
$8.3M
STRESS AND REPRODUCTIVE HORMONES IN DEPRESSIONR01MH050030 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZUBIETA, JON-KAR · 1994 to 2012
$3.6M
Dimensional RDoC Modeling across the Range of Negative Mood DysfunctionR01MH101487 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LANGENECKER, SCOTT A · 2013 to 2016
$2.5M
Depression Subtypes: Cognition, Emotion, NeurophysiologyK23MH074459 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LANGENECKER, SCOTT A · 2008 to 2012
$643k
NCRR NIH HHS M01 RR000042NIMH NIH HHS K23 MH074459NIMH NIH HHS P01 MH042251NIMH NIH HHS R01 MH050030NIMH NIH HHS R01 MH101487
6 · The paper itself

Abstract

Predicting treatment response for major depressive disorder can provide a tremendous benefit for our overstretched health care system by reducing number of treatments and time to remission, thereby decreasing morbidity. The present study used neural and performance predictors during a cognitive control task to predict treatment response (% change in Hamilton Depression Rating Scale pre- to post-treatment). Forty-nine individuals diagnosed with major depressive disorder were enrolled with intent to treat in the open-label study; 36 completed treatment, had useable data, and were included in most data analyses. Participants included in the data analysis sample received treatment with escitalopram (n = 22) or duloxetine (n = 14) for 10 weeks. Functional MRI and performance during a Parametric Go/No-go test were used to predict per cent reduction in Hamilton Depression Rating Scale scores after treatment. Haemodynamic response function-based contrasts and task-related independent components analysis (subset of sample: n = 29) were predictors. Independent components analysis component beta weights and haemodynamic response function modelling activation during Commission errors in the rostral and dorsal anterior cingulate, mid-cingulate, dorsomedial prefrontal cortex, and lateral orbital frontal cortex predicted treatment response. In addition, more commission errors on the task predicted better treatment response. Together in a regression model, independent component analysis, haemodynamic response function-modelled, and performance measures predicted treatment response with 90% accuracy (compared to 74% accuracy with clinical features alone), with 84% accuracy in 5-fold, leave-one-out cross-validation. Convergence between performance markers and functional magnetic resonance imaging, including novel independent component analysis techniques, achieved high accuracy in prediction of treatment response for major depressive disorder. The strong link to a task paradigm provided by use of independent component analysis is a potential breakthrough that can inform ways in which prediction models can be integrated for use in clinical and experimental medicine studies.

Indexed as

Cognition DisordersMajor Depressive DisorderTreatment OutcomeAdultAntidepressive AgentsCitalopramDuloxetine HydrochlorideFemaleHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsOxygenPredictive Value of TestsAntidepressive AgentsCitalopramDuloxetine HydrochlorideOxygenduloxetineescitalopramfunctional MRIindependent components analysismajor depressive disorder

Identifiers

PMID28122876
PMCPMC5278310
OpenAlexW2582718551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.